Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease

BACKGROUND: Fingolimod is the first oral immunomodulatory therapy approved for highly active relapsing remitting multiple sclerosis. Based on the distribution pattern of fingolimod interacting sphingosine-1-phosphat receptors in organism including immune system and cardiovascular system clinical mon...

Full description

Saved in:
Bibliographic Details
Main Authors: Thomas, Katja, Schrötter, Hagen, Halank, Michael, Ziemssen, Tjalf
Format: Artigo
Language:Inglês
Published: BioMed Central 2014
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4055797/
https://ncbi.nlm.nih.gov/pubmed/24906818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-14-126
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items